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Abstract Subtypes of purinergic receptors involved in
modulation of cytoplasmic calcium ion concentration
([Ca
2+]i) and insulin release in mouse pancreatic β-cells
were examined in two systems, pancreatic islets in
primary culture and beta-TC6 insulinoma cells. Both
systems exhibited some physiological responses such as
acetylcholine-stimulated [Ca
2+]i rise via cytoplasmic Ca
2+
mobilization. Addition of ATP, ADP, and 2-MeSADP (each
100 µM) transiently increased [Ca
2+]i in single islets
cultured in the presence of 5.5 mM (normal) glucose. The
potent P2Y1 receptor agonist 2-MeSADP reduced insulin
secretion significantly in islets cultured in the presence of
high glucose (16.7 mM), whereas a slight stimulation
occurred at 5.5 mM glucose. The selective P2Y6 receptor
agonist UDP (200 µM) transiently increased [Ca
2+]i and
reduced insulin secretion at high glucose, whereas the
P2Y2/4 receptor agonist UTP and adenosine receptor
agonist NECA were inactive. [Ca
2+]i transients induced
by 2-MeSADP and UDP were antagonized by suramin
(100 µM), U73122 (2 µM, PLC inhibitor), and 2-APB
(10 or 30 µM, IP3 receptor antagonist), but neither by
staurosporine (1 µM, PKC inhibitor) nor depletion of
extracellular Ca
2+. The effect of 2-MeSADP on [Ca
2+]i
was also significantly inhibited by MRS2500, a P2Y1
receptor antagonist. These results suggested that P2Y1 and
P2Y6 receptor subtypes are involved in Ca
2+ mobilization
from intracellular stores and insulin release in mouse
islets. In beta-TC6 cells, ATP, ADP, 2-MeSADP, and UDP
transiently elevated [Ca
2+]i and slightly decreased insulin
secretion at normal glucose, while UTP and NECA were
inactive. RT-PCR analysis detected mRNAs of P2Y1 and
P2Y6, but not P2Y2 and P2Y4 receptors.
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Introduction
Extracellular ATP and other purine nucleotides serve
important functions in regulating metabolism, energy
supply, and various cellular activities in many types of
cells and tissues [5, 40]. The effects of these agents are
mediated through specific P2 receptors that are subdivided
into P2X and P2Y families [23, 40]. The P2X receptors are
ionotropic, ligand-gated cation channels, whereas P2Y
receptors are G protein-coupled receptors [19, 23, 40]. At
present, seven P2X and eight P2Y receptor subtypes have
been cloned [23]. The role of nucleotides in the endocrine
function of the pancreas has been studied. Immunohisto-
chemical studies indicated the presence of P2X1, P2X4,
P2X7,P 2 Y 1,a n dP 2 Y 4 receptors in rat and mouse
pancreatic islets [8, 9]. Exogenous application of ATP and
other nucleotide derivatives has been reported to stimulate
insulin secretion in the rat pancreas and isolated rat islets
[3, 4, 6, 7, 11, 13, 26, 31, 32]. In addition, stimulation of a
P2Y receptor by ATP in rat pancreatic islets has been
shown to mobilize Ca
2+ from internal calcium sources via
phospholipase C (PLC) activation and the production of
inositol 1,4,5-trisphosphate (IP3)[ 4, 35] .T h er i s ei n
cytosolic Ca
2+ is a key event in the regulation of insulin
secretion in rat pancreatic islets [16]. In addition, stimula-
tion of insulin secretion through a P2Y receptor in rat islets
was suggested to be associated with the cAMP/PKA
pathway [7]. Enhancement of insulin release by ATP also
has been shown in the dog pancreas [35], human islets [12],
and several insulinoma cell lines [2, 15, 25, 37]. In
addition, ATP caused a transient increase in [Ca
2+]i in
mouse islet β-cells [16, 41], which was suggested to
involve internal calcium stores [41]. In contrast, ATP and
its related nucleotide analogues have been shown to inhibit
insulin secretion in mouse pancreatic islets [30, 33].
Poulsen et al. [33] have shown that a P2Y1 receptor and a
serine/threonine protein phosphatase calcineurin mediate
inhibition of exocytosis of insulin-containing vesicles in the
mouse β-cells. Recently, Zhao et al. showed that Ca
2+
mobilization induced by ATP differed in duration between
rat and mouse islet β-cells and suggested that the opposite
effect of ATP on insulin release in these two species is due
to the difference in the type of calcium ion channel being
affected [41]. These results suggest that a P2 receptor
subtype and [Ca
2+]i are closely associated with control of
insulin release. In the present study, we used selective
agonists and an antagonist of P2Y receptor subtypes [20,
21] to identify the particular receptor(s) involved in Ca
2+
mobilization and insulin release in mouse primary pancre-
atic islets in culture and the mouse β-cell line, beta-TC6.
The effect of various inhibitors of signaling molecules was
also examined in order to gain insight into the mechanism
whereby a P2Y receptor regulates insulin secretion in
mouse islet β-cells. The results suggest that P2Y receptor
subtypes, P2Y1 and P2Y6, are involved in the elevation of
[Ca
2+]i via Ca
2+ mobilization from intracellular stores and
inhibition of insulin secretion in mouse islet β-cells.
Experimental procedures
Reagents
ATP, UTP, ADP, UDP, NECA, suramin, U73122, U73343, 2-
APB, and staurosporine were obtained from the Sigma
Chemical Company (St. Louis, MO, USA). 2-MeSADP and
MRS2500 were from Tocris Bioscience (Bristol, UK). RPMI
1640 medium, Dulbecco’s modified Eagle’sm e d i u m
(DMEM), and penicillin/streptomycin were from Invitrogen
Corp. (Carlsbad, CA, USA). Fetal bovine serum (FBS) was
fromBioWest(Nuaill,France).U73122,U73343,2-APB,and
staurosporine were dissolved in dimethyl sulfoxide (DMSO).
Islet isolation
A pancreas from a male C57 BL/6 mouse (7–12 weeks old)
was inflated by injecting 1–2 ml Hank’s balanced salt solution
(HBSS, pH 7.4, Invitrogen, Carlsbad, CA, USA) containing
20 mM HEPES, 5 mM NaHCO3, 100 U/ml of penicillin,
100 µg/ml of streptomycin, and 1 mg/ml collagenase type XI
(Sigma, St. Louis, MO, USA) and digested for 15–20 min in
a water bath at 37°C. The digested tissues were filtered
through several metal and nylon meshes with repeated
washing with HBSS. Islets were collected on a 40-µm mesh
cell strainer (BD Biosciences, Bedford, MA, USA). Pancreatic
islets were placed on a 60-mm tissue culture dish (BD
Biosciences, Bedford, MA, USA) and cultured for approxi-
mately 1 day in RPMI 1640 medium containing 10% FBS,
100 U/ml ofpenicillin, 100 µg/mlof streptomycin, and5.5 mM
glucose. After initial culture, adequate numbers of islets
(100∼400) were picked by hand with a micropipette under a
stereomicroscope and used for the indicated experiments.
Cell culture
Beta-TC6 cells purchased from ATCC (Manassas, VA, USA)
were cultured in DMEM containing 10% FBS, 100 units/ml
penicillin, 100 µg/ml streptomycin, and 25 mM glucose in a
CO2 incubator (5% CO2) at 37°C. The cells were subcul-
tured every week. Cells from passage 10–30 were used for
all experiments.
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2+]i changes in single mouse islet
and beta-TC6 cells
Thirty islets were transferred into a glass-based dish coated
with collagen I (Asahi Techno Glass Corp., Tokyo, Japan)
a n dc u l t u r e df o r6 –10 days in RPMI 1640 medium
containing 5.5 mM glucose in 5% CO2 at 37°C. After
removal of the medium, islets were washed once with
Krebs/HEPES buffer (NaCl: 129 mM, NaHCO3: 5 mM,
KCl: 4.7 mM, MgSO4: 1.2 mM, KH2PO4: 1.2 mM, CaCl2:
2.56 mM, and HEPES: 10 mM, adjusted with 5N NaOH to
pH 7.4) without glucose and the islets were incubated for
20–30 min at 37°C in 5% CO2 in 1 ml of the buffer
containing 5.5 mM glucose and 3 µM of fura-2 acetox-
ymethyl ester (Invitrogen, Carlsbad, CA, USA). After one
wash with glucose-free buffer, 1 ml of the buffer containing
the desired glucose concentrations was added to the dish.
Reagent solutions were applied using a pipette. In single
islets the temporal change in [Ca
2+]i was monitored using a
microscope (Nikon, Tokyo, Japan) equipped with a fluores-
cence ratio analyzer (Hamamatsu Photonics, Hamamatsu,
Japan). The data were expressed as a ratio (340/380 nm) of
the fluorescence intensity (emission wavelength at 510 nm)
obtained when excited at a 340 or 380 nm wavelength. In
Figs. 3 and 5 and Table 1, the [Ca
2+]i response induced by
the nucleotide in the absence or presence of an inhibitor was
expressed as a change in the ratio (340/380 nm), which was
calculated by subtraction of a baseline value from a peak
height value. Inhibitors were dissolved in DMSO and mixed
well in assay buffer prior to application to the cells. The
volume of DMSO per 1 ml buffer was less than 3 µl since
5 µl of DMSO itself increased the baseline of the ratio.
Beta-TC6 cells (2×10
5 cells) were seeded in the glass-
based dish and cultured for 1 day in DMEM containing
25 mM glucose in 5% CO2 at 37°C. After reaching 40–50%
confluency, cells were washed with glucose-free Krebs/
HEPES buffer once and loaded with 3 µM fura-2
acetoxymethyl ester for 30–40 min at 37°C in darkness.
Then the incubation buffer was removed and replaced with
fresh Krebs/HEPES buffer (5.5 mM glucose). Measurement
of temporal changes in [Ca
2+]i in an islet-like cluster
composed of a few or several beta-TC6 cells was performed
with the same method as those mentioned above.
Insulin secretion assay
Isolated islets on a culture dish were preincubated for 60 min
at 37°C in 5% CO2 in Krebs/HEPES buffer containing
3.3 mM glucose. Groups of seven islets were manually
transferred to a centrifuge tube and incubated in 1 ml of
solution for 60 min at 37°C in the presence of indicated
concentrations of glucose, appropriate test agents, and bovine
serum albumin (1 mg/ml). After incubation, each tube was
centrifuged and the supernatant was stored frozen at −80°C
prior to the enzyme immunosorbent assay (EIA) of insulin.
Beta-TC6 cells were seeded in a 24-well plate at a
density of 1×10
5 cells/well and were grown at 37°C in the
CO2 incubator (5% CO2) for 4 days until the 40–50%
confluency was reached (2–4×10
5 cells/ml). Cells were
washed once with Krebs/HEPES buffer and preincubated
for 30 min in glucose-free buffer at 37°C. Then the
indicated concentration of glucose was added to each well
along with other reagents, and the plate was incubated for
90 min at 37˚Ci n5 %C O 2. At the end of the assay, a
supernatant was collected for insulin determination.
Insulin enzyme immunosorbent assay (EIA)
The concentration of insulin released into the assay buffer
from the mouse islets and beta-TC6 cells was measured using
Table 1 Effect of a P2Y1 receptor antagonist MRS2500, a P2 receptor antagonist suramin, a PKC inhibitor staurosporine, and depletion of
extracellular Ca
2+ on (a) 2-MeSADP- or (b) UDP-induced transient [Ca
2+]i rise in the mouse islet and beta-TC6 cells
+MRS2500 +Suramin +Staurosporine No extracellular Ca
2+
10 μM3 0 μM 100 μM1 μM
a
% of control (100 μM 2-MeSADP alone)
Mouse islet 49±11 (n=6)* 23±8 (n=5)* 15±7 (n=5)* 80±13 (n=3) 80±11 (n=7)
Beta-TC6 cells 35±4 (n=14)* 24±3 (n=16)* 49±10 (n=31)* 113±11 (n=24) 51±12 (n=30)*
b
% of control (200 μM UDP alone)
Mouse islet 11±6 (n =4)* 120±28 (n=5) 112±23 (n=6)
Beta-TC6 cells 51±6 (n=15)* 82±9 (n=32) 65±9 (n=24)*
MRS2500 and suramin were added with the nucleotides simultaneously to the culture of the islet or to beta-TC6 cells in the presence of 5.5 mM
glucose. The islet and beta-TC6 cells were preincubated with staurosporine for 20 min (mean±SE)
*P<0.05
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Yokohama, Japan), according to instructions of the company.
Each assay was run in duplicate and closely agreeing values
(less than 5% variation) were consistently obtained.
Reverse transcription-polymerase chain reaction (RT-PCR)
in islets and beta-TC6 cells
The total RNA of the mouse islets (500–1,000 islets) was
isolated with RNeasy Mini Kit (Qiagen, Germantown, MD,
USA) after genomic DNA was truncated using a QIAsh-
redder (Qiagen, Germantown, MD, USA). Beta-TC6 cells
were homogenized in a glass homogenizer on ice and the
total RNA was extracted with TRIzol reagent (Invitrogen,
Carlsbad, CA, USA) according to the method described
previously [28]. The total RNAs were then treated with
DNase I (Ambion, Austin, TX, USA) for 30 min at 37°C to
remove genomic DNA. The RNA (islets: 0.1 µg, beta-TC6
cells: 0.5 µg) was reverse transcribed into cDNA using a
GeneAmp RNA PCR kit (Applied Biosystems, Branch-
burg, NJ, USA) and then amplified by PCR with 40 or 30
cycles in the case of islets and beta-TC6 cells, respec-
tively. The oligo primers for mouse P2Y1,P 2 Y 2, P2Y4,
and P2Y6 receptor subtypes and β-actin (internal control)
were synthesized commercially (Operon Biotechnology,
Tokyo, Japan), according to the sequences for P2Y1,2,4,6
receptors [38] and β-actin [22]. These primer sequences
were as follows: P2Y1: sense 5′-TGGCGTGGTGTACCC
TCTCAAGTC-3′, antisense 5′-ACCGTGCTCGCAAATT
CATCGTT-3′,P 2 Y 2:s e n s e5 ′-ACCAGCGTGCGGG
GAACC-3′, antisense 5′-GCATCTCGGGCAAAGCGGA
CAAGT-3′,P 2 Y 4:s e n s e5 ′-TGCCTCGTGCCCAAC
CTCTTCTTT-3′, antisense 5′-CAGTTGTTCGGCGCT
TAGGTGTGC-3′,P 2 Y 6:s e n s e5 ′-CCTGGCACTGGCG
GACCTGAT-3′,a n t i s e n s e5 ′-GGCGGGCCATGCGA
CAATAAC-3′,a n dβ-actin: sense 5′-GATGACGA
TATCGCTGCGCTGGTCGTC-3′, antisense 5′-GACCCT
CAGGGCATCGGAACCGCTCG-3′. Annealing tempera-
tures for P2Y1,P 2 Y 2,P 2 Y 4,P 2 Y 6,a n dβ-actin in PCR were
57°C, 59°C, 60°C, 59°C and 65°C,respectively.Contamina-
tion of genomic DNA in the total RNAs was examined by
performing RT-PCR in the absence of a reverse transcriptase.
Electrophoresis of the amplified cDNA was performed on a
1.5% agarose gel containing ethidium bromide and the cDNA
wasvisualizedusingaUVtransilluminatorat302nm.
Statistics
Data were expressed as mean ± SE Statistical significance
was evaluated by Student’s t test. A P value < 0.05 was
statistically significant.
Results
Effect of purinergic agonists on [Ca
2+]i in mouse single
islets and beta-TC6 cells
We first examined the effect ofhigh concentrations of glucose
and acetylcholine (ACh), which are well-known potent
stimulators of [Ca
2+]i in the primary islet in culture [10,
14]. Both the increase of the glucose concentration from
5 . 5m Mt o 1 6 . 7m M( F i g .1a) and ACh at 100 µM (Fig. 1b)
induced an increase in [Ca
2+]i over a control that was
incubated in the presence of 5.5 mM glucose without ACh.
These results were consistent with previous findings [14].
We next examined the effect of various purinergic
compounds on [Ca
2+]i in mouse single islets in culture.
As shown in Fig. 2a, ATP at 100 µM induced a transient
increase in [Ca
2+]i, but it had little effect at 1 and 10 µM
(data not shown). In addition, both a synthetic analogue of
ADP, 2-MeSADP and ADP at 100 µM (data not shown),
which are P2Y1/12 receptor agonists, and a P2Y6 receptor-
selectiveagonistUDPat200µMstimulated[Ca
2+]i (Fig. 2b,c).
We found that UDP had little effect at 100 µM and that UTP,
which has a high affinity for P2Y2 and P2Y4 receptors, did
not elevate [Ca
2+]i even at 200 µM (data not shown). A
selective adenosine receptor agonist, NECA (200 µM) [34],
Fig. 1 Effect of a high concentration of glucose and acetylcholine
(ACh) on [Ca
2+]i in a single mouse islet in culture. Glucose at
16.7 mM (G16.7, a) and ACh at 100 μM( b) were added to the mouse
islet in the presence of 5.5 mM glucose (G5.5) at the time indicated by
the bar. The change in [Ca
2+]i was monitored for 30 min using
excitation at 340 and 380 nm and emission at 510 nm, and the bar
indicates exposure to the indicated nucleotide. Each experiment was
repeated 3 times
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or ADP did not raise [Ca
2+]i via adenosine receptors through
metabolic conversion to adenosine. To determine whether
[Ca
2+]i rises induced by the nucleotides were mediated
through purinergic receptors, we examined the effect of a
nonspecific P2 receptor antagonist, suramin, and a highly
specific P2Y1 receptor antagonist, MRS2500 [39], in the
mouse islet. Suramin (100 µM) significantly blocked both 2-
MeSADP- (100 µM) and UDP (200 µM)-induced transient
[Ca
2+]i elevations, suggesting that these responses were
mediated via the P2 receptor (Table 1). MRS2500 at 30 µM
significantly inhibited the [Ca
2+]i rise induced by
2-MeSADP (100 µM) in the islet, whereas it had a smaller
inhibitory effect at 10 µM (Table 1). The above results
indicated that P2Y1 and P2Y6 receptors were functional in
mouse pancreatic islets in culture.
ATP, 2-MeSADP, and ADP (data not shown) each at
100 µM and UDP at 200 µM also induced an increase in
Fig. 2 Effect of ATP, 2-MeSADP, and UDP on [Ca
2+]i in a single
mouse islet and beta-TC6 cells in culture. ATP at 100 μM( a, d), 2-
MeSADP at 100 μM( b, e), and UDP at 200 μM( c, f) were added to
the mouse single islet (a–c) and beta-TC6 cells (d–f) in the presence
of 5.5 mM glucose at the time indicated by the bar. In beta-TC6 cells,
[Ca
2+]i rise occurring in each islet-like cluster composed of a few or
several cells (9–10 clusters) is shown with overlapping different
colors. The change in [Ca
2+]i was monitored for 20 min using
excitation at 340 and 380 nm and emission at 510 nm, and the bar
indicates exposure to the indicated nucleotide. Each experiment was
repeated 7–15 times
Fig. 3 The effect of purinergic compounds on [Ca
2+]i in a mouse
single islet in culture and beta-TC6 cells. The following compounds
were tested: ATP (100 μM), 2-MeSADP (100 μM), ADP (100 μM),
and UDP (200 μM). The effect of the nucleotides on [Ca
2+]i is shown
as % of the peak response induced by ATP (100 μM) in the mouse
single islet in culture (a) and beta-TC6 cells (b) in the presence of
5.5 mM glucose. Each bar represents the mean±SE (n=7–15 in a
and n=24–54 in b)
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2+]i in mouse insulinoma beta-TC6 cells (Fig. 2d–f),
suggesting that the nucleotide-induced [Ca
2+]i increase in
pancreatic islets was attributable, at least in part, to the
response of β-cells in the islet. As shown in Table 1,t h e s e
effects both by 2-MeSADP and UDP were significantly
blocked by suramin (100 µM). The effect of 2-MeSADP
was also significantly inhibited by MRS2500 (10 or
30 µM).
Fig. 4 Effect of the PLC inhibitor U73122 and the IP3 receptor antagonist
2-APB on 2-MeSADP- or UDP-induced [Ca
2+]i rise in a single mouse
islet in culture. U73122 at 2 μM( a, c)a n d2 - A P Ba t3 0μM( b)o r
10 μM( d) were added to the islet 20 min prior to the addition of the
nucleotides. The change in [Ca
2+]i was monitored for 20 min using
excitation at both 340 and 380 nm and emission at 510 nm, and the bar
indicates exposure to the indicated nucleotide or the inhibitor. Each
experiment was repeated 3–4 times
Fig. 5 Effect of the PLC blocker U73122 and the IP3 receptor
antagonist 2-APB on 2-MeSADP- or UDP-induced [Ca
2+]i rise in
beta-TC6 cells. Cells were incubated in the presence of either 2 μM
U73122 (a, c)o r3 0μM 2-APB (b, d) for 20 min prior to addition of
the nucleotides. The results are expressed as a change in ratio
(calculated by subtraction of a baseline value from a peak height
value). Each bar represents the mean±SE (n=16–32). *P<0.05 in
comparison to control in the absence of nucleotides
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nucleotides on [Ca
2+]i, a peak height induced by each
nucleotide was expressed as % of that induced by 100 µM
ATP. The effect of 2-MeSADP on [Ca
2+]i appeared to be
almost the same as that of ATP in both the islet and beta-
TC6 cells, while the effect of UDP even at 200 µM was
smaller than that of ATP (Fig. 3a,b).
[Ca
2+]i transients induced by P2Y1 and P2Y6 receptor
activations are mediated through intracellular Ca
2+
mobilization
It has been demonstrated that both P2Y1 and P2Y6
receptors are Gq protein-coupled receptors and their
stimulation results in the activation of PLC, which produces
the second messengers IP3 and diacylglycerol (DG) [23,
40]. Then IP3 induces Ca
2+ mobilization from intracellular
stores in the endoplasmic reticulum and protein kinase C
(PKC) is activated by DG. In order to gain insight into the
mechanism of Ca
2+ mobilization induced by the nucleotides
in islets, we examined the effect of U73122, a PLC
inhibitor and an IP3 receptor inhibitor 2-APB. As shown
in Fig. 4a and c, U73122 at 2 µM significantly inhibited 2-
MeSADP- (100 µM) and UDP (200 µM)-induced [Ca
2+]i
increases, whereas U73343, an inactive analogue of
U73122, did not (data not shown). 2-APB also significantly
inhibited [Ca
2+]i rises induced by 2-MeSADP at 30 µM
(Fig. 4b) and UDP at 10 µM (Fig. 4d). The transient [Ca
2+]i
rises induced by both the nucleotides in the islet were still
observed when the extracellular Ca
2+ was depleted (Table 1).
By contrast, a PKC inhibitor staurosporine showed no
significant inhibitory effect. These results suggested the
involvement of intracellular Ca
2+ stores in the [Ca
2+]i
elevation induced by the P2Y1 and P2Y6 receptor activation,
whereas the PKC did not appear to play a role. Similar
inhibitory effects were observed in beta-TC6 cells (Fig. 5a–d
and Table 1). However, [Ca
2+]i responses induced by both
2-MeSADP and UDP were significantly inhibited in the
absence of extracellular Ca
2+ in beta-TC6 cells (Table 1). It
was possible that Ca
2+ influx through a Ca
2+ channel partly
contributed to the [Ca
2+]i elevation induced by stimulation of
P2Y1 or P2Y6 receptor in beta-TC6 cells.
Inhibitory effect of nucleotides on insulin secretion
in mouse islets and beta-TC6 cells
Both 2-MeSADP (100 µM) and UDP (200 µM) enhanced
glucose (5.5 mM)-induced insulin secretion in mouse islets
by 15 and 19%, respectively (Fig. 6a), however, these
effects were not statistically significant. In the presence of a
highconcentrationofglucose(16.7mMglucose),however,2-
MeSADPandUDPproducedsignificantinhibitionsofinsulin
secretion (P<0.05) by 39 and 43%, respectively (Fig. 6b). In
beta-TC6 cells cultured in the presence of 5.5 mM glucose
insulin secretion was also reduced by 2-MeSADP at 100 µM
and UDP at 200 µM, but these effects were smaller
(2-MeSADP: 81±4% compared with 5.5 mM glucose alone,
n=8; UDP: 84±9%, n=8). Among the nucleotides tested
(ATP, 2-MeSADP, ADP, and UDP), only the effect of
2-MeSADP was statistically significant.
P2Y1 and P2Y6 receptor mRNA expression in mouse islets
and beta-TC6 cells
The above pharmacological studies suggested that P2Y1
and P2Y6 receptors were present and functional in both the
mouse islets and beta-TC6 cells. We next examined
whether P2Y1,P 2 Y 2, P2Y4, and P2Y6 receptor mRNAs
were expressed by RT-PCR. As shown in Fig. 7a and b, the
P2Y1 and P2Y6 receptor mRNAs were present, whereas
expression of P2Y2 and P2Y4 receptor mRNAs was not
detectable in both the mouse islets and beta-TC6 cells. As a
Fig. 6 Effect of 2-MeSADP and UDP on insulin secretion in mouse
islets in culture. The islets were incubated in Krebs/HEPES buffer (pH
7.4) containing 5.5 mM (G5.5, a) or 16.7 mM glucose (G16.7, b)i n
the presence of 100 μM 2-MeSADP or 200 μM UDP for 60 min at
37°C. Each bar represents the mean±SE (n=8 in a and n=10 in b).
*P<0.05 in comparison to control in the absence of nucleotides
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the mouse brain was confirmed with the specific primers
(data not shown), indicating that failure to detect these
receptor mRNAs in β-cells was not due to the primer
sequences. The estimated sizes of the PCR products of
P2Y1 and P2Y6 receptors were the same in both the islets
and beta-TC6 cells.
Discussion
In the rat and mouse pancreas, P2X1, P2X4, P2X7, P2Y1,
P2Y2, and P2Y4 receptors were detected by immunohisto-
chemical studies [8, 9]. Recently, Garcia et al. reported by
RT-RCR and the Western blot analyses that P2Y1, P2Y2,
P2Y4, P2Y6, and P2Y12 receptors were expressed in rat
insulinoma INS-1 cells [27]. In the present study we found
that several P2Y receptor agonists elevated [Ca
2+]i in
mouse islets in culture in the presence of 5.5 mM glucose.
The findings that ATP, ADP, 2-MeSADP, and UDP but not
UTP induced [Ca
2+]i rises suggested the involvement of the
P2Y receptor, especially P2Y1 and P2Y6 receptors. RT-PCR
analysis also indicated that P2Y1 and P2Y6 receptors were
present in the islets. Our results are consistent with the view
that the P2Y1 receptor can regulate [Ca
2+]i in pancreatic β-
cells [14, 31, 39] and insulinoma [37]. In addition to the
P2Y1 receptor, we found that UDP, a selective activator of
the P2Y6 receptor, elicited a transient [Ca
2+]i increase and
inhibition of insulin release. These results suggested the
possible involvement of the P2Y6 receptor in the regulation
o fi n s u l i ns e c r e t i o ni nt h em o u s ei s l e t .H o w e v e r ,s i n c e
UDP produced its effect at the relatively high concen-
tration of 200 μM, we could not rule out the possibility
that the effect of UDP may be mediated via other
receptors. In our assay system, UDP-induced [Ca
2+]i
rises were blocked by 1 μM MRS2179 in mouse islets
(data not shown). There are several possibilities for the
blockade. The first possibility is that various indirect
effects could be produced when the nucleotides were
incubated for a long time with the cells, since [Ca
2+]i
measurements were performed under the static non-
perfusion assay conditions. The second one is that the
P2Y1 receptor couples with the P2Y6 receptor to form a
heterodimer and therefore the UDP effect is influenced by
the antagonist, since some functional recombinant hetero-
meric P2X receptors have been reported [20].
An earlier electrophysiological study also presented
evidence indicating that suppression of Ca
2+-dependent
exocytosis of insulin-containing granules was mediated via
the P2Y1 receptor in mouse primary islet β-cells [33]. It is
also noteworthy that insulin secretion was significantly
elevated in islets isolated from P2Y1-deficient mice
(P2Y1 −/−) in comparison to those from wild-type animals
[24], suggesting the involvement of the P2Y1 receptor in
inhibiting insulin secretion in the mouse islets. Since insulin
secretory granules contain ATP [18] and ATP is co-released
with insulin by pancreatic β-cells, it is possible that ATP
exerts a negative control over insulin secretion in a
feedback manner [33].
P2Y receptor activation enhanced moderate or high
glucose-induced insulin release in rat islets, whereas such an
enhancement was not observed in the presence of a low
glucose concentration [4, 7, 11, 13, 31, 32]. It was also
shown that pulsatile insulin secretion induced by high
glucose in rat islets was enhanced in the presence of
MRS2179 without affecting [Ca
2+]i oscillation [17, 36].
These results indicated that the P2Y1 receptor plays a role
in the regulation of insulin secretion in rat islets as well as in
Fig. 7 RT-PCR analysis of P2Y
receptor subtype mRNAs in
mouse islets and beta-TC6 cells.
PCR reactions were performed
by 40 cycles in the islets (a) and
by 30 cycles in beta-TC6 cells
(b) with specific primers for
each P2Y receptor subtype. The
expected PCR product lengths
for P2Y1, P2Y2, P2Y4, P2Y6,
and β-actin were 410, 440, 499,
452, and 778 bp, respectively.
Reverse transcription was per-
formed with (+) or without (−)a
reverse transcriptase to assess
genomic DNA contamination.
M shows a 100-bp DNA ladder
372 Purinergic Signalling (2008) 4:365–375mouse islets. In the present study, we found that stimulation
of the P2Y1 or P2Y6 receptor resulted in a significant
inhibition of high glucose (16.7 mM)-induced insulin
secretion, while they showed a slight potentiation (not
significant) at a normal glucose level (5.5 mM). The
decreased insulin secretion was consistent with those
amounts observed in the presence of stimulatory concen-
trations of glucose (10 or 15 mM) [30, 33]. Recently, we
found that both ADP and UDP exhibited inhibitory effects
on a sustained elevation and oscillations of [Ca
2+]i induced
by high glucose (16.7 mM) in the islet (preliminary data).
Taken together with the present results, it is suggested that
the transient increases in [Ca
2+]i are associated with the
slight stimulation, whereas the inhibitory effect on glucose-
induced [Ca
2+]i rises is related to the significant inhibition of
insulin release in mouse islets.
Very recently, Parandeh et al. reported that UDPβS, a
selective agonist for the P2Y6 receptor, stimulated insulin
release in mouse islets in vitro [29]. Its stimulatory effect
was observed at concentrations as low as 10 nM and reached
the maximum at concentrations ranging from 100 nM
to 1 μM that differed depending on the glucose
concentration. On the other hand, in the present study we
employed a high concentration of UDP, 200 μM, that
increased [Ca
2+]i in mouse islets and found that it inhibited
insulin secretion. It is clear that the opposite effect of UDP
on insulin secretion is related to its concentration used in the
two studies. Since we do not know the extracellular
concentration of UDP during insulin secretion in mouse
islets, it is not possible to evaluate the physiological
significance of UDP effects observed at the two different
concentrations. The possibility exists that UDP may produce
its dual effects on insulin secretion in a concentration-
dependent manner, i.e., a stimulatory effect at low concen-
trations and an inhibitory effect at high concentrations.
However, we cannot rule out the possibility that the
inhibitory effect of UDP at a high concentration is
pharmacological and is mediated via other receptors.
Both P2Y1 and P2Y6 receptors are coupled to the Gq
protein [23, 40]. We found that the effect of 2-MeSADP
and UDP on [Ca
2+]i was inhibited by inhibitors of PLC and
the IP3 receptor and still persisted in the absence of
extracellular Ca
2+ in the medium. These results suggest
that stimulation of the P2Y1 or P2Y6 receptor induces the
[Ca
2+]i elevation by mobilizing from intracellular stores
through the activation of a PLC/IP3 p a t h w a yi nt h em o u s e
islets. In a previous report, Zhao et al. showed that Ca
2+
mobilization induced by ATP differed in duration between
rat and mouse islet β-cells and suggested that the observed
opposite pattern of insulin release, i.e., stimulation and
inhibition between these two species, is due to the
difference in the type of a store-operated calcium ion
channel being involved [41].
It has been shown that protein kinases such as PKC and
PKA or protein phosphatases play a crucial role in the P2Y
receptor-mediated regulation of exocytosis in the islet β-
cells [1, 10, 33]. Previous studies showed that activation of
a cAMP/PKA pathway by the P2Y receptor enhanced
insulin release in the rat [7], whereas activation of serine/
threonine protein phosphatase calcineurin inhibited exocy-
tosis of insulin-containing granules in the mouse system
[33]. These findings suggested that activation of protein
kinases and phosphatases can play a key role in controlling
exocytosis of insulin-containing granules in the islet
β-cells. In the present study, however, we found that the
PKC inhibitor staurosporine had no effect on 2-MeSADP- or
UDP-induced [Ca
2+]i rises. Thus, PKC did not appear to
contribute to the generation of the nucleotide-induced
[Ca
2+]i rises in the mouse islets.
The islet contains α-, β-, and δ-cells, and only β-cells
produce and secrete insulin [14]. In order to examine
whether the effect of 2-MeSADP and UDP on [Ca
2+]i was
related to β-cells in the islet, we employed beta-TC6
insulinoma cells as another experimental β-cell model. We
found that beta-TC6 cells, like the pancreatic islets,
responded to the purinergic nucleotides in terms of [Ca
2+]i
and insulin secretion. The response occurred in the presence
of 5.5 mM glucose. Our previous study showed that these
cells had a lower threshold for glucose so that 5.5 mM
glucose elicited the maximal insulin secretion in these
insulinoma cells [28]. We also found by RT-PCR analysis
that the P2Y1 and P2Y6 receptors also were expressed in
beta-TC6 cells. There is no clear evidence that a functional
P2 receptor is present in other types of cells such as α-cells
in the islet. These results suggested that the effect of
nucleotides on [Ca
2+]i and insulin secretion in the mouse
islet can be attributable to β-cells.
In summary, we present evidence indicating that the
mouse islets and beta-TC6 cells possess a P2Y1 or P2Y6
receptor and respond to the purinergic agonists by
increasing [Ca
2+]i via intracellular Ca
2+ mobilization and
modulation of insulin secretion. These purinergic receptors,
especially the P2Y6 receptor, may play a role as autocrine
regulators of insulin release and may serve as a target for
treatment of diabetes mellitus.
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